{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6Tj78JDA","lastupdate":"2024-02-15T00:00:00.000Z","update_date":"2024-02-15T00:00:00.000Z","lastModified":"May 14, 2025","active":1,"confidence_score":99,"confidence_score_reason":"markets","urlname":"sanoculis","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$mrcsvC510myVi9vQvc12YyUjdxkdMBWsOvpgKvDH9qt9hrV0T4tNn0.png","name":"Sanoculis","oneliner":"Minimally Invasive Surgical Device for Glaucoma Treatment","registrar":"514733724","website":"https://sanoculis.com","careerspage":"","founded_month":2,"founded_year":2012,"formernames":[],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCT1KBtmpyTEvqDlwL5BG6mQ","facebook":"","linkedin":"https://www.linkedin.com/company/68842608","instagram":""},"social":["https://www.youtube.com/channel/UCT1KBtmpyTEvqDlwL5BG6mQ","https://www.linkedin.com/company/68842608"],"flattenedsociallinks":"https://www.youtube.com/channel/UCT1KBtmpyTEvqDlwL5BG6mQ|https://www.linkedin.com/company/68842608","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"1-10","employees_exact":9,"patent":1,"raised":18500000,"stage":"C","public_stage":"C","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Sanoculis offers a new alternative surgical procedure for treating glaucoma. Its Minimally Invasive Micro Sclerostomy (MIMS) solution consists of a single-patient-use sterile tool and a multi-use external machine. In the course of the surgery, a sclero-corneal drainage channel is created to reduce intraocular pressure.\r\n\r\nMIMS is a microfluidic full-thickness procedure developed as an advanced laser sclerostomy. The technique uses a cutting and drilling device to reduce trauma to the surrounding tissue, minimizing scar tissue formation and allowing for a long-lasting filtering bleb. The MIMS channel ensures a controlled fluid flow with minor complications.\r\n\r\nIn March 2017, Sanoculis was granted CE marking for its MIMS device and procedure.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97235503432","country":null,"address":{"israeli":[{"id":"3ebae873-fdab-4698-92d8-bed5fa23cdc7","city":"Kiryat Ono","type":null,"address":"Landau Street 10, Kiryat Ono, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"1LuhkjGUO4iQcoOEfc2RRdSvxx9ygIITt7rYLfNI8ucCRI5nC6BUNI","date":"Apr 17, 2025","link":"https://www.prnewswire.com/il/news-releases/sanoculis-receives-ce-mark-for-mint-product-for-the-treatment-of-glaucoma-302431644.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"CE Mark Approval","round":null,"company":"Sanoculis Ltd.","layoffs":null,"summary":"Sanoculis Ltd., a company specializing in ophthalmic medical device technologies, has received CE Mark approval under the Medical Device Regulation (MDR) in the EU for its MINT® product. MINT® is a stent-free technology platform designed for glaucoma angle surgery, offering a less invasive and more effective treatment option. The approval marks a significant milestone for Sanoculis, allowing them to proceed with a selective commercial pre-launch rollout later this year. The MINT® technology has shown promising results in clinical studies, indicating its safety and effectiveness in lowering intraocular pressure and reducing the need for glaucoma medications. This development is expected to enhance the standard of care for glaucoma patients.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["Glaucoma","MINT","CE Mark","Medical Device","Ophthalmic"],"date_of_event":null,"product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"not mentioned","structuredIssuesShow":"#Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"xfY3TXdWaWo2N4K1duzKjVgDYoIgUfi23IVOif5up9ZKfMVNPxHodP","news_summary":"/PRNewswire/ -- Sanoculis Ltd., a company specializing in ophthalmic medical device technologies, today announced that it has received CE Mark approval under...","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Dx4KdWfIEak6yuqxw9h5Uu5wcziSe3swlIPHYA7P0zHlLvR3T9Qxka","date":"Apr 17, 2025","link":"https://www.prnewswire.com/il/news-releases/sanoculis-receives-ce-mark-for-mint-product-for-the-treatment-of-glaucoma-302431454.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical device","round":null,"company":"Sanoculis Ltd.","layoffs":null,"summary":"Sanoculis Ltd., a company specializing in ophthalmic medical device technologies, has received CE Mark approval in the EU for its MINT® (Minimally Invasive Nasal Trabeculostomy) product. This innovative, stent-free technology platform is designed for the treatment of glaucoma and aims to improve patient outcomes by offering a less invasive, more effective treatment option. Clinical data indicates that MINT® is safe and effective in lowering intraocular pressure and reducing the need for glaucoma medications. Sanoculis plans a selective commercial pre-launch rollout of the MINT® technology later this year. The approval marks a significant step forward for the company, potentially elevating the standard of care in glaucoma treatment.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["glaucoma","MINT technology","CE Mark approval","minimally invasive","ophthalmic devices"],"date_of_event":null,"product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"not mentioned","structuredIssuesShow":"#Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"LAGLG95Cuxf0rxUiscwawbuzm1pD0WqjJHhJsHZ1s7SDeOR1XyN2WK","news_summary":"/PRNewswire/ -- Sanoculis Ltd., a company specializing in ophthalmic medical device technologies, today announced that it has received CE Mark approval under...","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1WgLco4Vv88hJnMG6mukGSpn7jEmlefuVLmhorS8ZpLKJLe5YfY2g7","date":"Jan 25, 2023","link":"https://www.prnewswire.com/news-releases/eckuity-joins-bausch--lomb-in-an-equity-investment-in-sanoculis-301729936.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Investment, Partners, Acquisition","company":"Sanoculis","layoffs":"Not Mentioned","summary":"Eckuity, a venture capital investor based in New York and London, has invested in Sanoculis, an Israeli ophthalmic medical device company, as part of a Series C funding round. Bausch + Lomb also invested and entered into an exclusive European distribution agreement with Sanoculis for its Minimally Invasive Micro Sclerostomy (MIMS®), a surgical procedure for glaucoma treatment. The companies have also entered into an option agreement, giving Bausch + Lomb the option to purchase all of Sanoculis assets.","partners":["Bausch + Lomb"],"customers":"Not Mentioned","investors":["Eckuity","Bausch + Lomb"],"confidence":9,"key_topics":["Investment","Partnership","Glaucoma Treatment","Distribution Agreement","Option Agreement"],"date_of_event":"Not Mentioned","valuation_amount":"Not Mentioned","impact_on_company":"Growth-Positive","investment_amount":"Not Mentioned","structured_issues":["Investment","Partners","Acquisition"],"acquisition_amount":"Not Mentioned","structuredIssuesShow":"#Investment  #Partners  #Acquisition","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"Growth-Positive","analysisId":"S2WBMTo3KeYlSBiNDMwPN6FTuN9lPldqcJWXzscuKZFJjdogEyWUa3","news_summary":"Eckuity Joins Bausch + Lomb in an Equity Investment in Sanoculis","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"CSgMQvh7hSUmF9cfHf7rigSv1BIi00YfrV6xYiR2wAqojSvHWYfTzx","date":"Jul 28, 2022","link":"https://www.prnewswire.com/il/news-releases/bausch--lomb-and-sanoculis-announce-strategic-agreements-designed-to-address-unmet-needs-in-glaucoma-301594887.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Investment, Partnership","company":"Bausch + Lomb Corporation, Sanoculis","layoffs":"Not mentioned","summary":"Bausch + Lomb Corporation has made an equity investment in Sanoculis, an Israeli ophthalmic medical device start-up, as part of a Series C funding round. The companies have also entered into an exclusive European distribution agreement for Sanoculis Minimally Invasive Micro Sclerostomy (MIMS), a surgical procedure for the treatment of glaucoma. The partnership aims to address unmet needs in glaucoma treatment, with MIMS offering a stentless, simple, and fast treatment that lowers intraocular pressure without invasive surgery. The companies have also entered into an option agreement, giving Bausch + Lomb the option to purchase all of Sanoculis assets.","partners":"Sanoculis","customers":"Not mentioned","investors":"Bausch + Lomb Corporation","confidence":9,"key_topics":["Equity Investment","Distribution Agreement","Glaucoma Treatment","MIMS Procedure","Series C Funding"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Investment","Partners"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"v2dzDYd26tJ3IgxTtknWvIz8llwPNueGzSZxsDsv96waUtYElbDDz5","news_summary":"Bausch + Lomb and Sanoculis Announce Strategic Agreements Designed to Address Unmet Needs in Glaucoma","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"dfeb14c5-e331-49de-8296-4a43e6b52f46","date":"Mar 21, 2017","link":"https://eyewire.news/articles/sanoculis-receives-ce-mark-for-its-minimally-invasive-micro-sclerostomy-mims-device/?utm_source=facebook&utm_medium=social&utm_content=51197993","source":"eyewire.news","visible":1,"analysis":{"tags":"Ophthalmic News","company":"Eyewire+","layoffs":null,"summary":"Eyewire+ is a platform that provides updates on the latest developments in the ophthalmic field. The information is sourced from press releases, medical journals, vision publications, videos, and other news sources.","partners":[],"customers":[],"investors":[],"confidence":10,"key_topics":["Ophthalmic News"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"Neutral","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"entityGrowthIconPath":"none;"},"sentiment":"Neutral","analysisId":"lzbAj6n8bq4Ci1CjRMyvbF6vWjtXeETzgS3LYLJql3BwcEjZJ6HL9m","news_summary":"News - Eyewire+","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"31a10cab-bd78-4fd3-8bd8-78c37ff7fd4e","date":"Aug 25, 2016","link":"http://www.globes.co.il/en/article-alfred-manns-biomedical-legacy-1001148384","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Medical Equipment, Startups, Investment","company":"MannKind Corporation","layoffs":"N/A","summary":"The Mann Foundation for Biomedical Engineering and the Alfred Mann Institute at the Technion, both part of the legacy of late billionaire philanthropist and medical equipment entrepreneur Alfred Mann, are continuing to support medical equipment startups following Manns death. The Mann Foundation manages two funds that encourage applied research into startups at two universities, including the Technion Israel Institute of Technology. The foundation currently manages $85m and expects to increase this to $400m in the next two to three years.","partners":"Technion Israel Institute of Technology","customers":"N/A","investors":"Mann Foundation for Biomedical Engineering, Alfred Mann Institute at the Technion","confidence":"8","key_topics":"Medical Equipment, Startups, Investment, Innovation, Biomedical Engineering","date_of_event":"August 25, 2016","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"$85 million","structured_issues":"Investment, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Investment, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"92svmuFKtzDGy4DQNMySdsO2FdkhDBMjf95iHuXfyeXoxgcRnnyzVE","news_summary":"Alfred Mann's legacy stimulates Israeli innovation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a0a025ac-7447-42b6-8d2f-1f39f7040a33","date":"May 10, 2016","link":"https://www.healio.com/ophthalmology/glaucoma/news/print/ocular-surgery-news/%7Be1be2619-cca2-40cb-8ff4-28062463f4ee%7D/minimally-invasive-micro-sclerostomy-may-be-alternative-to-trabeculectomy","source":"www.healio.com","visible":1,"analysis":{"tags":"Healthcare, Medical Technology","company":"Sanoculis","layoffs":"N/A","summary":"Sanoculis, a medical technology company, has developed a new surgical technique called Minimally Invasive Micro Sclerostomy (MIMS) for treating patients with glaucoma. The technique combines the mechanism of conventional trabeculectomy and simple needling, and is designed to control intraocular pressure (IOP) with fewer complications. Preliminary trials of the MIMS procedure have shown promising results in primary open-angle glaucoma patients, with a 95.5% success rate in creating a drainage channel. However, long-term IOP control and morphological variations induced by conjunctival or sclera fibrotic changes need to be evaluated in future studies.","partners":"N/A","customers":"Patients with glaucoma","investors":"N/A","confidence":8,"key_topics":["Minimally Invasive Micro Sclerostomy","Glaucoma Surgery","Trabeculectomy","Intraocular Pressure","Surgical Tool"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers","acquisition_amount":"N/A","structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"eK00qjq7yycOshQaPgu9LQCf8IDCmOYBPBGaPBro7glO0Z92JSP0z8","news_summary":"Minimally invasive micro sclerostomy may be alternative to trabeculectomy","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":7,"techcommunityinvolvement":null,"mediagallery":[{"id":"82211cf5-721f-4896-aaa2-c2952e19e5f8","timestamp":"2020-12-02 09:00:22.000000","resources_type":2,"resources_title":"","resources_file_name":"NzzY-ZQhXHI","alt":"","imageurl":"https://img.youtube.com/vi/NzzY-ZQhXHI/0.jpg","url":"http://youtu.be/NzzY-ZQhXHI"},{"id":"29f3fa9f-95e0-4b79-a6dc-2b391d2f3f25","timestamp":"2020-03-17 09:07:34.000000","resources_type":2,"resources_title":"","resources_file_name":"8a3SyzERWY4","alt":"","imageurl":"https://img.youtube.com/vi/8a3SyzERWY4/0.jpg","url":"http://youtu.be/8a3SyzERWY4"},{"id":"8643b1e1-7d09-4430-9274-4e7c0a78f800","timestamp":"2016-06-21 13:23:01.000000","resources_type":2,"resources_title":"","resources_file_name":"tjrq-otsucY","alt":"","imageurl":"https://img.youtube.com/vi/tjrq-otsucY/0.jpg","url":"http://youtu.be/tjrq-otsucY"}],"tags":["minimally-invasive","surgery","glaucoma","hospitals","surgeons","ophthalmology","medical-devices","healthcare-providers","eye-diseases","clinics","treatments"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuXyawKDA"],"technologysuccessstory":[{"date":"2012-02-01","name":"Alternative new surgical procedure for the treatment of Glaucoma","tags":["glaucoma","minimally-invasive","medical-devices","ophthalmology","surgery"],"category":"Medical Devices","tto_logo":"/image_cloud/t3_tto_logo_f5fde2b3-6016-11e8-abf1-41fdcbb0dda6","university_logo":"/image_cloud/t3_institution_logo_f5fde2b3-6016-11e8-abf1-41fdcbb0dda6"},{"date":"2012-02-01","name":"Minimally invasive surgical procedure for glaucoma treatment","tags":["ophthalmology","glaucoma","medical-devices","minimally-invasive","eye-diseases"],"category":"Medical Devices","tto_logo":"/image_cloud/tel-hashomer_tto_logo_5471b6e8-b5d5-11e8-8a10-c14be16af9ea","university_logo":"/image_cloud/tel-hashomer_institution_logo_5471b6e8-b5d5-11e8-8a10-c14be16af9ea"}],"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":["MIMS"],"geomarkets":["India","China","Europe"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":6,"lastfunding":"$14M","totalrounds":3,"fundingstage":"C","totalfunding":"$18.5M","publicinvestors":4,"lastpublicfunding":14000000,"totalpublicrounds":2,"totalpublicfunding":15000000},"team":[{"name":"Nir Israeli","email":"nir@sanoculis.com","phone":"0546852005","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGywLgIDA","bounced":false,"claimed":1,"founder":1,"urlname":"nir-israeli-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA3o7W9AgM","position":"Co-founder & CEO","last_name":"Israeli","claimtoken":"4099ae16c92e22ce8a471780c1126fb45943e55a775971427c4ed72c45c75c8e","first_name":"Nir","picturekey":"$7ASZn6pQTzV78V02qygF6eTGbZylLSFEUu3Xep3gNooWPi6kKVIfRT","claimeddate":"2016-12-25","linkedinurl":"https://www.linkedin.com/in/nir-israeli-37500a56/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2016-12-22 09:46:20.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$7ASZn6pQTzV78V02qygF6eTGbZylLSFEUu3Xep3gNooWPi6kKVIfRT","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Vadim Shmukler","email":"vadim@sanoculis.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLG1y6sJDA","bounced":false,"claimed":0,"founder":1,"urlname":"vadim-shmukler","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAsYWH7gkM","position":"Co-founder & CTO","last_name":"Shmukler","claimtoken":"U3bn4seG56YeWGv2jBXlxYwhjVWLo2IYA3QEGcR45hGL3xjyuHyOy1","first_name":"Vadim","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/vadim-shmukler-25363b4/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-02-15 16:18:09.000000","initials":"VS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dr. Yoseph Glovinsky","email":"yoseph@sanoculis.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGhqM0IDA","bounced":true,"claimed":0,"founder":1,"urlname":"dr-yoseph-glovinsky","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAsd_23ggM","position":"Co-founder & Medical Director","last_name":"Glovinsky","claimtoken":"azpHN8SWBkUZ88lqwbwFVJhimPv4znW47zxsFy9wf81kaElzuZs9h0","first_name":"Dr. Yoseph","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-02-15 16:18:16.000000","initials":"DG","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Elad Shalev","email":"elad@sanoculis.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkOiklNILDA","bounced":false,"claimed":0,"founder":0,"urlname":"elad-shalev-2","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQiK3d4AoM","position":"VP of Global Marketing & Sales","last_name":"Shalev","claimtoken":"Cq4qUxywBeDst370p2vDt00TQU8R3Ln3LhT5dtyKwVzaN4wsWSEGWA","first_name":"Elad","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/elad-shalev-a19b932/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-01-16 18:45:35.000000","initials":"ES","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgN7UwIEIDA","fullname":"Aviv Alper"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverifydate":"2020-03-17T00:00:00.000Z","crunchbaseid":"sanoculis","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":null,"creator_email":null,"createdate":"2015-01-06T00:00:00.000Z","biverification":"Natalia Golczar","sectorverification":"Aviv Alper","affiliatedOrganizations":null,"timeline":[{"id":"rWimJmFuRZwzKrGxI7sNYzuq2MUgHtFpZOq4d9lLaNJrxhgzzdnaev","date":"Jul 2022","amount":"$14M","source":"https://www.prnewswire.com/il/news-releases/bausch--lomb-and-sanoculis-announce-strategic-agreements-designed-to-address-unmet-needs-in-glaucoma-301594887.html, https://www.prnewswire.com/news-releases/eckuity-joins-bausch--lomb-in-an-equity-investment-in-sanoculis-301729936.html","eventtype":"FundingRoundEvent","investment":[{"name":"Bausch + Lomb","type":"Company","amount":null,"hidden":true,"country":"United States","fullurl":"/company_page/bausch-lomb","logokey":"$mXDOq04n4tGnbNlNakShDzF7cYIGOknI1WXJdsMvh6kH2Er0GDmfif","tagline":"leading global eye health company","urlname":"/company_page/bausch-lomb","isisraeli":0,"investorid":"xRS96s71wyhzLrIFWUrNpwD4wy3yyeoIUO0gCT17kk4KmMd80PluSv","fundingtype":"Company","leadpartner":null,"investmentid":"1w8t61f73lCml8BWEcnuarFrXkxy6JrTbhJmgAInc1MD7VsLkfvYow","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mXDOq04n4tGnbNlNakShDzF7cYIGOknI1WXJdsMvh6kH2Er0GDmfif","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Eckuity","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/eckuity","logokey":"$Gyu9oVTpZgNeOhDlddUpaAINjR1PdcBGQ0bm2X4lFqCCdEUaiB4rYV.png","tagline":null,"urlname":"/investor_page/eckuity","isisraeli":0,"investorid":"D2CcGm7ZPh8pauEMI7iMxtOHxhTeAhBPgGcvY7lJauyQ3rNVUA16YQ","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"lSrTzlJ7KrBNiKJGUHnVtw9mryFnEtSVI9C51PoUBFMRZF6Ouu7Qqj","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Gyu9oVTpZgNeOhDlddUpaAINjR1PdcBGQ0bm2X4lFqCCdEUaiB4rYV.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Infinity Group","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/infinity-group","logokey":"$QEAi2tyxiJFjMogFAX9jgh8zsEX480FZlLx0Y0hPRolEZpiQCEAvpv","tagline":null,"urlname":"/investor_page/infinity-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKma3oYKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"zFAliuBOls9KZqVHS9KRT9bv4eEHSeUXtmzRPnhE4nzOoN0e0WQAex","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$QEAi2tyxiJFjMogFAX9jgh8zsEX480FZlLx0Y0hPRolEZpiQCEAvpv","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":14000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEnJHbCQw","date":"Sep 2019","amount":"$3.5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"HCS Capital ","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/hcs-capital-1","logokey":"$uO1vDaQlww9SFuXzAN5ILCEyOO3fYIWTjaW07ALo80kYY2dEcKQFzA","tagline":null,"urlname":"/investor_page/hcs-capital-1","isisraeli":1,"investorid":"U3LytdXJ2nrZDikJu5y4Ul5LaWd1yuL7YalpAXy42Fk8fWcK3IIbrc","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0VaJEMvG6gTcHCz5m9MJI0LomFQiujXK4QHQkk8lZlyFlflXLlLzbz","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$uO1vDaQlww9SFuXzAN5ILCEyOO3fYIWTjaW07ALo80kYY2dEcKQFzA","leadcaption":"","followupcaption":""},{"name":"BIOLIGHT Life Sciences","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/biolight-life-sciences","logokey":"$o8uyrhM0wkd8QeEmyBfNubbEEho5Lj78MYmFcMCSp47nIciiCCyo5h","tagline":null,"urlname":"/investor_page/biolight-life-sciences","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4OeL444IDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"UwHGOfAvHTc0IZ3UD2PDhm6tRWAeqpqS1XFlEBuVV0M7Z3dYnXRZ2s","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$o8uyrhM0wkd8QeEmyBfNubbEEho5Lj78MYmFcMCSp47nIciiCCyo5h","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE1cPkCgw","date":"Aug 2016","amount":"$1M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Zohar Zisapel (Late)","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/zohar-zisapel-late","logokey":"$fY9gkx8oSW04GxrCverTwHHcQ5R1ZjVyZlqjx4uyQmB4TXoOP4vgeQ","tagline":null,"urlname":"/investor_page/zohar-zisapel-late","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwKfprI0LDA","fundingtype":"Angel","leadpartner":null,"investmentid":"exeOZYshhHNq6uixHgCPySAezybTkeHsZF5jrtnqsJqy57kKZOZt14","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$fY9gkx8oSW04GxrCverTwHHcQ5R1ZjVyZlqjx4uyQmB4TXoOP4vgeQ","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"2/2012","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Sanoculis","logourl":"https://storage.googleapis.com/clean-finder-353810/$mrcsvC510myVi9vQvc12YyUjdxkdMBWsOvpgKvDH9qt9hrV0T4tNn0.png","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$mrcsvC510myVi9vQvc12YyUjdxkdMBWsOvpgKvDH9qt9hrV0T4tNn0.png","seoabout":"Sanoculis offers a new alternative surgical procedure for treating glaucoma. Its Minimally Invasive Micro Sclerostomy (MIMS) solution consists of a single-...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":4,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":2,"name":"Laser","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuXyawKDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA>Laser#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuXyawKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA|2:>TechnologyClassificationModel>Sensing#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA/Laser#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuXyawKDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Sensing","key":"0-0","path":"TechnologyClassificationModel>Sensing","children":[{"title":"Laser","key":"0-0-0","path":"TechnologyClassificationModel>Sensing>Laser"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Sensing","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LvQ9JYJDA","classificationName":"coretechnology"},{"depth":2,"name":"Laser","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuXyawKDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Sensing","Laser"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"rWimJmFuRZwzKrGxI7sNYzuq2MUgHtFpZOq4d9lLaNJrxhgzzdnaev","date":"Jul 2022","amount":"$14M","source":"https://www.prnewswire.com/il/news-releases/bausch--lomb-and-sanoculis-announce-strategic-agreements-designed-to-address-unmet-needs-in-glaucoma-301594887.html, https://www.prnewswire.com/news-releases/eckuity-joins-bausch--lomb-in-an-equity-investment-in-sanoculis-301729936.html","eventtype":"FundingRoundEvent","investment":[{"name":"Bausch + Lomb","type":"Company","amount":null,"hidden":true,"country":"United States","fullurl":"/company_page/bausch-lomb","logokey":"$mXDOq04n4tGnbNlNakShDzF7cYIGOknI1WXJdsMvh6kH2Er0GDmfif","tagline":"leading global eye health company","urlname":"/company_page/bausch-lomb","isisraeli":0,"investorid":"xRS96s71wyhzLrIFWUrNpwD4wy3yyeoIUO0gCT17kk4KmMd80PluSv","fundingtype":"Company","leadpartner":null,"investmentid":"1w8t61f73lCml8BWEcnuarFrXkxy6JrTbhJmgAInc1MD7VsLkfvYow","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mXDOq04n4tGnbNlNakShDzF7cYIGOknI1WXJdsMvh6kH2Er0GDmfif","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Eckuity","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/eckuity","logokey":"$Gyu9oVTpZgNeOhDlddUpaAINjR1PdcBGQ0bm2X4lFqCCdEUaiB4rYV.png","tagline":null,"urlname":"/investor_page/eckuity","isisraeli":0,"investorid":"D2CcGm7ZPh8pauEMI7iMxtOHxhTeAhBPgGcvY7lJauyQ3rNVUA16YQ","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"lSrTzlJ7KrBNiKJGUHnVtw9mryFnEtSVI9C51PoUBFMRZF6Ouu7Qqj","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Gyu9oVTpZgNeOhDlddUpaAINjR1PdcBGQ0bm2X4lFqCCdEUaiB4rYV.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Infinity Group","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/infinity-group","logokey":"$QEAi2tyxiJFjMogFAX9jgh8zsEX480FZlLx0Y0hPRolEZpiQCEAvpv","tagline":null,"urlname":"/investor_page/infinity-group","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKma3oYKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"zFAliuBOls9KZqVHS9KRT9bv4eEHSeUXtmzRPnhE4nzOoN0e0WQAex","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$QEAi2tyxiJFjMogFAX9jgh8zsEX480FZlLx0Y0hPRolEZpiQCEAvpv","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"C Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":14000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEnJHbCQw","date":"Sep 2019","amount":"$3.5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"HCS Capital ","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/hcs-capital-1","logokey":"$uO1vDaQlww9SFuXzAN5ILCEyOO3fYIWTjaW07ALo80kYY2dEcKQFzA","tagline":null,"urlname":"/investor_page/hcs-capital-1","isisraeli":1,"investorid":"U3LytdXJ2nrZDikJu5y4Ul5LaWd1yuL7YalpAXy42Fk8fWcK3IIbrc","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"0VaJEMvG6gTcHCz5m9MJI0LomFQiujXK4QHQkk8lZlyFlflXLlLzbz","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$uO1vDaQlww9SFuXzAN5ILCEyOO3fYIWTjaW07ALo80kYY2dEcKQFzA","leadcaption":"","followupcaption":""},{"name":"BIOLIGHT Life Sciences","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/biolight-life-sciences","logokey":"$o8uyrhM0wkd8QeEmyBfNubbEEho5Lj78MYmFcMCSp47nIciiCCyo5h","tagline":null,"urlname":"/investor_page/biolight-life-sciences","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4OeL444IDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"UwHGOfAvHTc0IZ3UD2PDhm6tRWAeqpqS1XFlEBuVV0M7Z3dYnXRZ2s","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$o8uyrhM0wkd8QeEmyBfNubbEEho5Lj78MYmFcMCSp47nIciiCCyo5h","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE1cPkCgw","date":"Aug 2016","amount":"$1M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Zohar Zisapel (Late)","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/zohar-zisapel-late","logokey":"$fY9gkx8oSW04GxrCverTwHHcQ5R1ZjVyZlqjx4uyQmB4TXoOP4vgeQ","tagline":null,"urlname":"/investor_page/zohar-zisapel-late","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwKfprI0LDA","fundingtype":"Angel","leadpartner":null,"investmentid":"exeOZYshhHNq6uixHgCPySAezybTkeHsZF5jrtnqsJqy57kKZOZt14","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$fY9gkx8oSW04GxrCverTwHHcQ5R1ZjVyZlqjx4uyQmB4TXoOP4vgeQ","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}